Increased levels of nuclear IL-33 protein are present in trephine biopsies of BCR-ABL1-negative MPN patients, and high amounts of circulating soluble ST2 were detected in the plasma from CML patients, compared to controls. This evidence concerns the gene IL33 and myeloproliferative neoplasm.